Haefeli WE - Search Results

1

Undeclared exposure to St. John's Wort in hospitalized patients.

Martin-Facklam M, Rieger K, Riedel KD, Burhenne J, Walter-Sack I, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2004 Oct;58(4):437-41. doi: 10.1111/j.1365-2125.2004.02169.x. Br J Clin Pharmacol. 2004. PMID: 15373938 Free PMC article.

2

[Drug interactions with the cytochrome P-450 system].

Martin-Facklam M, Drewe J, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Dtsch Med Wochenschr. 2000 Jan 21;125(3):63-7. doi: 10.1055/s-2007-1023908. Dtsch Med Wochenschr. 2000. PMID: 10682001 Review. German. No abstract available.

3

[Consideration of drug absorption in customizing drug therapy].

Walter-Sack I, Haefeli WE. Walter-Sack I, et al. Among authors: haefeli we. Ther Umsch. 2000 Sep;57(9):557-62. doi: 10.1024/0040-5930.57.9.557. Ther Umsch. 2000. PMID: 11036435 Review. German.

4

[Clinically relevant adverse drug interactions].

Martin-Facklam M, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Ther Umsch. 2000 Sep;57(9):579-83. doi: 10.1024/0040-5930.57.9.579. Ther Umsch. 2000. PMID: 11036439 Review. German.

5

Drug dosage in patients with renal failure optimized by immediate concurrent feedback.

Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Falconnier AD, et al. Among authors: haefeli we. J Gen Intern Med. 2001 Jun;16(6):369-75. doi: 10.1046/j.1525-1497.2001.016006369.x. J Gen Intern Med. 2001. PMID: 11422633 Free PMC article.

6

Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement.

Tayrouz Y, Ganssmann B, Ding R, Klingmann A, Aderjan R, Burhenne J, Haefeli WE, Mikus G. Tayrouz Y, et al. Among authors: haefeli we. Clin Pharmacol Ther. 2001 Nov;70(5):405-14. doi: 10.1067/mcp.2001.119212. Clin Pharmacol Ther. 2001. PMID: 11719726 Clinical Trial.

7

[Framework for biomedical research involving human subjects - algorithms for planning and organisation].

Walter-Sack I, Haefeli WE. Walter-Sack I, et al. Among authors: haefeli we. Dtsch Med Wochenschr. 2002 Mar 22;127(12):627-33. doi: 10.1055/s-2002-22673. Dtsch Med Wochenschr. 2002. PMID: 11907867 German. No abstract available.

8

Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.

Martin-Facklam M, Burhenne J, Ding R, Fricker R, Mikus G, Walter-Sack I, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2002 Jun;53(6):576-81. doi: 10.1046/j.1365-2125.2002.01595.x. Br J Clin Pharmacol. 2002. PMID: 12047481 Free PMC article. Clinical Trial.

9

Highly sensitive determination of saquinavir in biological samples using liquid chromatography-tandem mass spectrometry.

Burhenne J, Riedel KD, Martin-Facklam M, Mikus G, Haefeli WE. Burhenne J, et al. Among authors: haefeli we. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 5;784(2):233-42. doi: 10.1016/s1570-0232(02)00803-6. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12505771

10

Quality markers of drug information on the Internet: an evaluation of sites about St. John's wort.

Martin-Facklam M, Kostrzewa M, Schubert F, Gasse C, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Am J Med. 2002 Dec 15;113(9):740-5. doi: 10.1016/s0002-9343(02)01256-1. Am J Med. 2002. PMID: 12517364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters